Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• The human telomerase catalytic component (hTERT) can restore telomerase activity in somatic cells.
• Replicating telomerase activity in normal cells can extend their lifespan.

Purpose of the Study:

• To investigate if expressing hTERT in normal human somatic cells induces a malignant phenotype.
• To assess the impact of sustained telomerase expression on cellular growth control and tumor formation.

Main Methods:

• Human skin fibroblasts (BJ-hTERT) and retinal pigment epithelial cells (RPE-hTERT) were engineered to express hTERT.
• Cells were subjected to various growth control assays, including serum deprivation, high cell density, cell cycle blockers, and spindle inhibitors.
• Tumorigenicity was assessed through in vivo studies and soft agar colony formation assays.

Main Results:

• Telomerase-expressing cells (BJ-hTERT and RPE-hTERT) maintained normal growth control under various stress conditions.
• No evidence of uncontrolled proliferation or neoplastic transformation was observed.
• Cells did not form tumors in vivo or colonies in soft agar, indicating a lack of malignant potential.

Conclusions:

• Telomerase expression in normal human somatic cells extends replicative lifespan without inducing malignant transformation.
• Sustained hTERT expression does not confer the characteristics of a cancerous phenotype.
• These findings suggest that telomerase activation alone is insufficient to cause cancer in normal cells.